Opzelura cream for mild-to-moderate eczema
Treatments studied
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests a cream called Opzelura (ruxolitinib) for people with mild-to-moderate eczema on at least two body areas. It aims to see how well the cream works in everyday use for people ages 2 and older.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 2 years old or older.
- You have mild-to-moderate eczema (atopic dermatitis) on at least two different body areas.
- Your eczema covers 20% or less of your total body surface.
- If you are a woman who could become pregnant, you are using a reliable birth control method.
- You are not currently pregnant.
- You are not taking other strong eczema treatments like phototherapy, biologics, or changing systemic medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the health of mothers and their babies in two groups: women with eczema who used ruxolitinib cream during pregnancy and those who did not. It aims to see if the cream is safe for both mother and child.
This study looks at women who used a topical eczema cream called ruxolitinib (Opzelura) or steroid creams during pregnancy. The goal is to compare pregnancy outcomes and baby health up to one year after birth.
This trial tests if an ointment called QLM3003 is safe and helps adults with mild to moderate atopic dermatitis (eczema). It may be a new treatment option for people whose eczema affects small areas of skin.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
This trial tests whether a new cream (FilmoCream) plus steroid ointment works better than steroid ointment alone for mild-to-moderate eczema. You must have two separate eczema patches that need steroid treatment.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.